Navigation Links
QBC Diagnostics Awarded GSA Contract
Date:4/23/2012

PORT MATILDA, Penn., April 23, 2012 /PRNewswire/ -- QBC Diagnostics, a global manufacturer of hematology and infectious disease diagnostics equipment, announced today that the company has been awarded a U.S. General Services Administration (GSA) Schedule 66 Contract for Scientific Equipment and Services.

GSA's Scientific Equipment and Services Schedule 66 Contract provides federal agencies with scientific instruments for a wide variety of uses such as public safety, medical research, and laboratory diagnostics. Under contract number GS-07F-0306Y, QBC Diagnostics has been approved to sell to government agencies for all of their major product lines, including the QBC STAR Hematology Analyzer and the QBC ParaLens Advance Fluorescence Microscopy Attachment.

"We are thrilled to be able to offer an efficient and reliable means of supplying our government partners with our entire line of products," said Craig Stout, QBC Diagnostics' General Manager and Vice President. "QBC is highly committed to providing our customers with innovative tools such as our unique line of dry hematology analyzers and fluorescence microscopy products, and this contract further strengthens our past relationships with government agencies."

Currently, QBC has a number of its QBC STAR Hematology analyzers installed on over 250 U.S. Navy Vessels, including both surface and submarine forces. Working closely with the U.S. Department of State, QBC diagnostics also provides hematology solutions to more than 50 United States Embassies worldwide. The QBC ParaLens Advance can be found in a number of National Tuberculosis Programs around the globe, and is considered a leader in the field of fluorescence microscopy.

QBC Diagnostics is presently working on finalizing their contract price list with GSAAdvantage!®, which should be made available shortly. In the interim, QBC has asked that all inquiries pertaining to GSA pricing should be directed to their sales team for further information.

About QBC Diagnostics

QBC Diagnostics is a privately held company headquartered in Port Matilda, Pennsylvania.  The company manufactures a line of complete blood count analyzers and fluorescence microscopy products.  Additional information can be found by visiting the company website (www.qbcdiagnostics.com) or by calling +1-814-692-7661.  Follow QBC on Twitter or Facebook for further updates.


'/>"/>
SOURCE QBC Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics Names Steve Rusckowski as President and CEO
2. FDA Clears the Quest Diagnostics Simplexa® C. difficile Molecular Test
3. Everist Genomics Develops Worlds First Comprehensive Companion Diagnostics and Prognostics Portfolio for Early Diagnosis and Improved Treatment of Colorectal Cancer
4. QIAGEN Expands Access to State-of-the-art HPV Screening in China Through Co-marketing Agreement With KingMed Diagnostics
5. Quest Diagnostics to Speak at the 2012 Barclays Capital Global Healthcare Conference
6. Hemostasis Diagnostics Market Leading Suppliers and Emerging Market Entrants
7. Quest Diagnostics Declares Quarterly Cash Dividend
8. Quest Diagnostics to Speak at the 2012 RBC Capital Markets Healthcare Conference
9. Care360® EHR From Quest Diagnostics Honored by Black Books 2012 Rankings and Capterras Top 20 List
10. Quest Diagnostics Offers Industry-First 30-Day Ambulatory EHR Implementation Guarantee for Hospitals and IDNs
11. Aria Diagnostics Announces Name of New Non-Invasive Prenatal Assay - Harmony Prenatal Test™ - and Publication of Study on Specimen Transport
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017 Abdominal Aortic Aneurysm Repair Devices Market was valued at $1,844 ... a CAGR of 5.1% from 2016 to 2022. The endovascular stent graft system segment ... during the study period. Continue Reading ... ... ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... 2022" report to their offering. ... The global wound care market was worth $24,482.9 million in ... during 2016-2022 Among the various wound care products type, the ... market in 2015. Among the various applications, surgical wound segment held the ...
(Date:3/24/2017)... , March 24, 2017 ShangPharma, ... high-quality and cost-effective drug development and discovery ... and biotechnology industry, announced today the intent ... ShangPharma will be consolidating the Contract Research ... under Shanghai ChemPartner. These entities include ChemPartner ...
Breaking Medicine Technology:
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... to the military at the same time by providing Prehospital Trauma Life Support ... PHTLS is the world’s premier prehospital trauma education developed in cooperation with the ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... from third world countries to hospitals in the United States, it’s a threat ... on the current obstacles facing infection prevention and offers strategies for the healthcare ...
(Date:3/24/2017)... ... , ... The Radiology Business Management Association (RBMA) has named the ... their 12th year, are among the most prestigious in radiology marketing because a panel ... retooled to recognize achievements in both large budget (over $5,000) and small budget (under ...
(Date:3/24/2017)... ... ... Texas Physical Therapy Specialists (TexPTS) is pleased to announce the opening ... is the group’s 7th location in San Antonio and 23rd in Texas. Dr. ... from the clinic, which opened March 22, 2017. , The team of ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mlynarek Insurance Agencies, a Detroit ... business owners across eastern Michigan, is connecting with the Oxford/Orion FISH Food Pantry ... , The Oxford/Orion FISH Food Pantry works to ensure homeless, hungry, and underprivileged ...
Breaking Medicine News(10 mins):